Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE) two randomised, d...

Wykoff Charles C., Abreu Francis, Adamis Anthony P., Basu Karen, Eichenbaum David A., Haskova Zdenka, Lin Hugh, Loewenstein Anat, Mohan Shaun, Pearce Ian A., Sakamoto Taiji, Schlottmann Patricio G., Papp András, Tóth-Molnár Edit, Kollaborációs szervezet: YOSEMITE and RHINE Investigators
2022

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2) 12-month results from a randomised, double-masked, phase 3 trial /

Khanani Arshad M, Patel Sunil S, Staurenghi Giovanni, Tadayoni Ramin, Danzig Carl J, Eichenbaum David A, Hsu Jason, Wykoff Charles C, Heier Jeffrey S, Lally David R, Monés Jordi, Nielsen Jared S, Sheth Veeral S, Kaiser Peter K, Clark Julie, Zhu Liansheng, Patel Hersh, Tang Justin, Desai Dhaval, Jaffe Glenn J, Kollaborációs szervezet: GATHER2 trial investigators, Tóth-Molnár Edit
2023